Antidepressant Usage in Haemodialysis Patients: Evidence of Sub-Optimal Practice Patterns.
Ayman GuirguisJoseph ChilcotMichael AlmondAndrew DavenportDavid WellstedKenneth FarringtonPublished in: Journal of renal care (2020)
Antidepressant management in patients on haemodialysis reflected poor drug selection, overprescription, under-dosing and inadequate follow-up suggesting sub-optimal adherence to NICE guidelines. Most patients had high depression scores at follow-up. Antidepressant use in haemodialysis requires reappraisal.